ROCKET PHARMACEUTICALS, INC. — Director's Dealing 2024

Feb 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ROCKET PHARMACEUTICALS, INC. (RCKT)
CIK: 0001281895
Period of Report: 2024-02-14

Reporting Person: Wilson Martin (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-14	Common Stock	M	9712	—	Disposed	9712	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-14	Restricted Stock Units	$	M	9712	Disposed		Common Stock (9712)	Direct

Footnotes

F1: Represents shares of Common Stock received upon vesting of a restricted stock unit ("RSU") award.

F2: Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.

F3: One-third (1/3) of such RSUs became fully vested and exercisable on February 14, 2024, with the remaining shares vesting in equal quarterly installments over the following two years.